DOSSIER · 13F-HR · Q2 2026

Jones Hill Capital LP

$470M in tracked AUM across 29 positions as of Q2 2026.

JH
CIK 0002102314 · last filed Jun 30, 2026
Total AUM
$470M
as of Q2 2026
Holdings
29
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Jones Hill Capital LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
BMRN
BIOMARIN PHARMACEUTICAL INC
$82M1.4M17.4%
02
GILD
GILEAD SCIENCES INC
$43M343K9.2%
03
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$29M1.1M6.1%
04
MDGL
MADRIGAL PHARMACEUTICALS INC
$28M53K6.0%
05
BCAX
BICARA THERAPEUTICS INC
$27M893K5.6%
06
RLMD
RELMADA THERAPEUTICS INC
$25M3.7M5.4%
07
TRVI
TREVI THERAPEUTICS INC
$25M1.3M5.3%
08
N69605108
PHARVARIS N V
$23M678K5.0%
09
XENE
XENON PHARMACEUTICALS INC
$22M368K4.7%
10
ANIP
ANI PHARMACEUTICALS INC
$19M234K4.1%

Filing history

2026Q2Jun 30
$470M 0.8%
29 positionsView →
2026Q1Mar 31
$466M
26 positionsView →